PNC Financial Services Group Inc. Sells 18,730 Shares of Bruker Corporation $BRKR

PNC Financial Services Group Inc. cut its stake in shares of Bruker Corporation (NASDAQ:BRKR) by 86.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,943 shares of the medical research company’s stock after selling 18,730 shares during the period. PNC Financial Services Group Inc.’s holdings in Bruker were worth $96,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in BRKR. Sector Gamma AS grew its holdings in Bruker by 28.0% during the third quarter. Sector Gamma AS now owns 250,909 shares of the medical research company’s stock worth $8,152,000 after purchasing an additional 54,939 shares during the period. New York State Common Retirement Fund increased its holdings in shares of Bruker by 52.5% in the third quarter. New York State Common Retirement Fund now owns 370,797 shares of the medical research company’s stock valued at $12,047,000 after purchasing an additional 127,698 shares during the last quarter. DNB Asset Management AS bought a new position in shares of Bruker in the second quarter valued at about $4,201,000. Jefferies Financial Group Inc. bought a new position in Bruker in the 2nd quarter valued at about $2,361,000. Finally, OMERS ADMINISTRATION Corp increased its stake in shares of Bruker by 15.2% during the second quarter. OMERS ADMINISTRATION Corp now owns 212,200 shares of the medical research company’s stock worth $8,743,000 after purchasing an additional 28,000 shares during the period. Institutional investors and hedge funds own 79.52% of the company’s stock.

Insider Buying and Selling at Bruker

In related news, VP Mark Munch sold 2,000 shares of the business’s stock in a transaction on Thursday, January 15th. The shares were sold at an average price of $49.20, for a total transaction of $98,400.00. Following the transaction, the vice president owned 128,443 shares in the company, valued at $6,319,395.60. The trade was a 1.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 27.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. JPMorgan Chase & Co. boosted their target price on shares of Bruker from $50.00 to $55.00 and gave the company an “overweight” rating in a research report on Monday, December 15th. Bank of America raised their price target on Bruker from $43.00 to $60.00 and gave the stock a “buy” rating in a research report on Monday, December 15th. The Goldman Sachs Group decreased their target price on shares of Bruker from $40.00 to $35.00 and set a “sell” rating on the stock in a report on Friday, February 13th. Guggenheim boosted their price objective on shares of Bruker from $53.00 to $58.00 and gave the company a “buy” rating in a research report on Monday, January 26th. Finally, Zacks Research raised shares of Bruker from a “strong sell” rating to a “hold” rating in a report on Monday, December 8th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $50.38.

Bruker Price Performance

Shares of BRKR opened at $38.50 on Friday. The company has a market capitalization of $5.86 billion, a price-to-earnings ratio of -256.67, a price-to-earnings-growth ratio of 2.30 and a beta of 1.19. Bruker Corporation has a 1 year low of $28.53 and a 1 year high of $56.22. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.73 and a quick ratio of 0.87. The business has a 50-day moving average of $44.90 and a 200-day moving average of $40.94.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings data on Thursday, February 12th. The medical research company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.06). The firm had revenue of $977.20 million for the quarter, compared to analyst estimates of $964.61 million. Bruker had a positive return on equity of 13.56% and a negative net margin of 0.25%.The company’s quarterly revenue was down .2% compared to the same quarter last year. During the same quarter last year, the company earned $0.76 earnings per share. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, equities research analysts anticipate that Bruker Corporation will post 2.69 earnings per share for the current year.

Bruker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 7th. Shareholders of record on Monday, March 23rd will be paid a $0.05 dividend. The ex-dividend date of this dividend is Monday, March 23rd. This represents a $0.20 annualized dividend and a yield of 0.5%. Bruker’s payout ratio is -133.33%.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.